遺伝子編集の世界市場の予測（～2030年）

世界の遺伝子編集の市場規模は、予測期間中にCAGRで20.9%の成長が予測されています。

地域の考察

北米の市場規模は、2022年に20億米ドルを超え、調査期間中にCAGRで21.19％の成長が見込まれます。悪性腫瘍などの遺伝性疾患の拡大、個別化医療への傾倒の高まり、官民領域における資金調達の拡大、シーケンシングと遺伝子編集のイノベーションの迅速な進歩が市場を牽引しています。

欧州市場は第2位の市場シェアを占める見込みです。CRISPRフレームワークを製造するコンピューター推論（AI）の利用のような医療サービスITにおける技術の進歩が、市場の発展を促進しています。

アジア太平洋市場は、2023年～2030年にCAGRで24.03％の発展が見込まれています。

中東は中東・アフリカにおいて大きな市場シェアを占めています。政府支援の発展や、官民組織の台頭、補助金の拡大などが、この地域のバイオテクノロジー産業の発展に寄与しています。

当レポートでは、世界の遺伝子編集市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

• 概要
• 促進要因
  • 遺伝子研究への資金提供の増加
  • 遺伝子疾患の発生率の増加
  • 戦略的取り組みの増加
• 抑制要因
  • CRISPR技術のオフターゲット効果
  • 高い設備費
• 機会
  • 遺伝子編集の応用分野の拡大

第5章 市場要因の分析

• バリューチェーン分析
  • 研究開発設計
  • 製造
  • 流通、販売
  • 販売後ニタリング
• ポーターのファイブフォース分析モデル
• 世界の遺伝子編集市場に対するCOVID-19の影響
  • サプライチェーンに対する影響
  • 地域に対する影響
  • 供給ギャップに対する影響の分析
  • 価格に対する影響

第6章 世界の遺伝子編集市場：技術別

• 概要
• CRISPR
• TALEN
• ZFN
• アンチセンス
• その他

第7章 世界の遺伝子編集市場：用途別

• 概要
• 遺伝子工学
• 遺伝子治療
• 細胞株工学
• その他

第8章 世界の遺伝子編集市場：エンドユーザー別

• 概要
• バイオテクノロジー企業、製薬企業
• 開発業務受託機関
• 学術、政府研究機関

第9章 世界の遺伝子編集市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• その他の地域
  • 中東
  • アフリカ
  • ラテンアメリカ

第10章 競合情勢

• 概要
• 競合ベンチマーキング
• 世界の遺伝子編集市場における主な成長戦略
• 世界の遺伝子編集市場における開発数の主要企業
• 主な開発の分析
• 主な発展と成長戦略
  • 製品の拡張と発売
  • 契約/協力
• 財務マトリクス
  • 売上（2021年）
  • 研究開発支出（2021年）

第11章 企業プロファイル

• BIO-RAD LABORATORIES, INC
• GE HEALTHCARE
• GENSCRIPT
• INTEGRATED DNA TECHNOLOGIES, INC
• NEW ENGLAND BIOLABS
• SANGAMO THERAPEUTICS
• THERMO FISHER SCIENTIFIC, INC
• LONZA
• HORIZON DISCOVERY LTD
• ORIGENE TECHNOLOGIES, INC

第12章 付録

LIST OF TABLES

• TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
• TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
• TABLE 3 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 36
• TABLE 4 GLOBAL GENE EDITING MARKET, FOR CRISPR, BY REGION, 2019-2030 (USD MILLION) 36
• TABLE 5 GLOBAL GENE EDITING MARKET, FOR TALEN, BY REGION, 2019-2030 (USD MILLION) 37
• TABLE 6 GLOBAL GENE EDITING MARKET, FOR ZFN, BY REGION, 2019-2030 (USD MILLION) 37
• TABLE 7 GLOBAL GENE EDITING MARKET, FOR ANTISENSE, BY REGION, 2019-2030 (USD MILLION) 37
• TABLE 8 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION) 38
• TABLE 9 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 41
• TABLE 10 GLOBAL GENE EDITING MARKET, FOR GENETIC ENGINEERING, BY REGION, 2019-2030 (USD MILLION) 41
• TABLE 11 GLOBAL GENE EDITING MARKET, FOR GENE THERAPY, BY REGION, 2019-2030 (USD MILLION) 42
• TABLE 12 GLOBAL GENE EDITING MARKET, FOR CELL LINE ENGINEERING, BY REGION, 2019-2030 (USD MILLION) 42
• TABLE 13 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION) 42
• TABLE 14 GLOBAL GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 45
• TABLE 15 GLOBAL GENE EDITING MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2019-2030 (USD MILLION) 45
• TABLE 16 GLOBAL GENE EDITING MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2030 (USD MILLION) 46
• TABLE 17 GLOBAL GENE EDITING MARKET, FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019-2030 (USD MILLION) 46
• TABLE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2019-2030 (USD MILLION) 47
• TABLE 19 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 50
• TABLE 20 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 51
• TABLE 21 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 51
• TABLE 22 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 51
• TABLE 23 US: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 52
• TABLE 24 US: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 52
• TABLE 25 US: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 52
• TABLE 26 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 53
• TABLE 27 CANADA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 53
• TABLE 28 CANADA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 53
• TABLE 29 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 55
• TABLE 30 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 56
• TABLE 31 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 56
• TABLE 32 EUROPE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 57
• TABLE 33 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 57
• TABLE 34 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 58
• TABLE 35 GERMANY: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 58
• TABLE 36 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 58
• TABLE 37 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 59
• TABLE 38 FRANCE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 59
• TABLE 39 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 59
• TABLE 40 UK: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 60
• TABLE 41 UK: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 60
• TABLE 42 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 60
• TABLE 43 ITALY: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 61
• TABLE 44 ITALY: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 61
• TABLE 45 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 61
• TABLE 46 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 62
• TABLE 47 SPAIN: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 62
• TABLE 48 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 62
• TABLE 49 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 63
• TABLE 50 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 63
• TABLE 51 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 65
• TABLE 52 ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 65
• TABLE 53 ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 66
• TABLE 54 ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 66
• TABLE 55 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 67
• TABLE 56 CHINA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 67
• TABLE 57 CHINA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 68
• TABLE 58 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 68
• TABLE 59 INDIA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 68
• TABLE 60 INDIA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 69
• TABLE 61 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 69
• TABLE 62 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 70
• TABLE 63 JAPAN: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 70
• TABLE 64 AUSTRALIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 71
• TABLE 65 AUSTRALIA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 71
• TABLE 66 AUSTRALIA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 71
• TABLE 67 SOUTH KOREA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 72
• TABLE 68 SOUTH KOREA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 72
• TABLE 69 SOUTH KOREA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 72
• TABLE 70 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 73
• TABLE 71 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 73
• TABLE 72 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 73
• TABLE 73 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2019-2030 (USD MILLION) 75
• TABLE 74 REST OF THE WORLD: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 75
• TABLE 75 REST OF THE WORLD: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 76
• TABLE 76 REST OF THE WORLD: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 76
• TABLE 77 MIDDLE EAST: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 77
• TABLE 78 MIDDLE EAST: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 77
• TABLE 79 MIDDLE EAST: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 77
• TABLE 80 AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 78
• TABLE 81 AFRICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 78
• TABLE 82 AFRICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 78
• TABLE 83 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 79
• TABLE 84 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 79
• TABLE 85 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 79
• TABLE 86 MAJOR PLAYERS IN THE GLOBAL GENE EDITING MARKET 80
• TABLE 87 MOST ACTIVE PLAYER IN THE GLOBAL GENE EDITING MARKET 82
• TABLE 88 PRODUCT EXPANSION AND LAUNCH: GLOBAL GENE EDITING MARKET 83
• TABLE 89 AGREEMENT/COLLABORATION: GLOBAL GENE EDITING MARKET 84
• TABLE 90 BIO-RAD LABORATORIES, INC: PRODUCTS OFFERED 87
• TABLE 91 GE HEALTHCARE: PRODUCTS OFFERED 90
• TABLE 92 GENSCRIPT: PRODUCTS OFFERED 93
• TABLE 93 GENSCRIPT: KEY DEVELOPMENTS 93
• TABLE 94 INTEGRATED DNA TECHNOLOGIES, INC: PRODUCTS OFFERED 95
• TABLE 95 INTEGRATED DNA TECHNOLOGIES, INC: KEY DEVELOPMENTS 96
• TABLE 96 NEW ENGLAND BIOLABS: PRODUCTS OFFERED 97
• TABLE 97 SANGAMO THERAPEUTICS: PRODUCTS OFFERED 100
• TABLE 98 SANGAMO THERAPEUTICS: KEY DEVELOPMENTS 100
• TABLE 99 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 103
• TABLE 100 LONZA: PRODUCTS OFFERED 106
• TABLE 101 LONZA: KEY DEVELOPMENTS 106
• TABLE 102 HORIZON DISCOVERY LTD: PRODUCTS OFFERED 107
• TABLE 103 HORIZON DISCOVERY LTD: KEY DEVELOPMENTS 107
• TABLE 104 ORIGENE TECHNOLOGIES, INC: PRODUCTS OFFERED 109

LIST OF FIGURES

• FIGURE 1 MARKET SYNOPSIS 15
• FIGURE 2 GLOBAL GENE EDITING MARKET 16
• FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22
• FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL GENE EDITING MARKET 25
• FIGURE 5 DRIVER IMPACT ANALYSIS 27
• FIGURE 6 RESTRAINT IMPACT ANALYSIS 28
• FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL GENE EDITING MARKET 29
• FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL GENE EDITING MARKET 31
• FIGURE 9 GLOBAL GENE EDITING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, (USD MILLION) 35
• FIGURE 10 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2022 & 2030 (USD MILLION) 35
• FIGURE 11 GLOBAL GENE EDITING MARKET SHARE (%), BY TECHNOLOGY, 2022 36
• FIGURE 12 GLOBAL GENE EDITING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD MILLION) 40
• FIGURE 13 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 40
• FIGURE 14 GLOBAL GENE EDITING MARKET SHARE (%), BY APPLICATION, 2022 41
• FIGURE 15 GLOBAL GENE EDITING MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 43
• FIGURE 16 GLOBAL GENE EDITING MARKET, BY END USER, 2022 & 2030 (USD MILLION) 44
• FIGURE 17 GLOBAL GENE EDITING MARKET SHARE (%), BY END USER, 2022 45
• FIGURE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 47
• FIGURE 19 GLOBAL GENE EDITING MARKET SHARE (%), BY REGION, 2022 48
• FIGURE 20 NORTH AMERICA MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 49
• FIGURE 21 NORTH AMERICA: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 50
• FIGURE 22 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 50
• FIGURE 23 EUROPE MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 54
• FIGURE 24 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 55
• FIGURE 25 EUROPE: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 56
• FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 64
• FIGURE 27 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 64
• FIGURE 28 ASIA-PACIFIC: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 65
• FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 74
• FIGURE 30 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 74
• FIGURE 31 REST OF THE WORLD: GENE EDITING MARKET SHARE (%), BY REGION, 2022 75
• FIGURE 32 BENCHMARKING OF MAJOR COMPETITORS 81
• FIGURE 33 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL GENE EDITING MARKET 82
• FIGURE 34 GLOBAL GENE EDITING MARKET: COMPETITIVE LANDSCAPE 83
• FIGURE 35 SALES 2021 84
• FIGURE 36 RESEARCH & DEVELOPMENT EXPENDITURE, 2021 85
• FIGURE 37 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT 87
• FIGURE 38 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS 88
• FIGURE 39 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 90
• FIGURE 40 GE HEALTHCARE: SWOT ANALYSIS 91
• FIGURE 41 GENSCRIPT: FINANCIAL OVERVIEW SNAPSHOT 92
• FIGURE 42 GENSCRIPT: SWOT ANALYSIS 94
• FIGURE 43 SANGAMO THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT 99
• FIGURE 44 SANGAMO THERAPEUTICS: SWOT ANALYSIS 101
• FIGURE 45 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 103
• FIGURE 46 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 104
• FIGURE 47 LONZA: FINANCIAL OVERVIEW SNAPSHOT 105

Market Overview

The Gene editing Market size is projected to register a CAGR of 20.9% during the forecast period. The developing number of key drives and expanding subsidizing for genetic exploration are main considerations driving the market development.

Genomic editing alludes to the procedures and methods used to alter the genetic data of any living life form. Genome editing includes the alteration of genes in numerous areas utilizing recombinant innovation, which increments addition accuracy and diminishes cell poisonousness. An assortment of innovations permits researchers to modify a creature's DNA. These advancements empower adding, erasing, or changing genetic material at explicit areas inside the genome. Ascend in the quantity of key drives as consolidations, acquisitions, item endorsement, coordinated efforts, and organizations to acquire an upper hand and proposition progressed treatment choices for genomic editing.

Market Segmentation

Technology-based segments of the gene editing market include CRISPR, TALEN, ZFN, antisense, and others.

Genetic engineering, gene therapy, cell line engineering, and other applications make up the market segments of gene editing.

Gene editing market segmentation is based on biotechnology and pharmaceutical firms, contract research organizations (CROs), university & government research institutes, and contract research organizations (CROs).

Regional Insights

The North American gene editing market is supposed to represent over USD 2 billion in 2022 and is supposed to show a 21.19% CAGR during the review time frame. This is credited to the expansion of malignant growth and other genetic problems, a developing inclination for customized medication, an expansion in private and public area financing, and quick progressions in sequencing and gene editing innovations are driving the market for gene editing in the North America region.

Europe gene editing market is supposed to represent the second-biggest market share because of mechanical headways in medical services IT like the utilization of Computerized reasoning (man-made intelligence) to fabricate CRISPR frameworks are driving development drive the market development of gene editing in Europe.

The Asia-Pacific gene editing market is supposed to develop at a CAGR of 24.03% from 2023 to 2030. This is because of the rising mechanical leap forwards, a flourishing biotechnology industry in arising regions, and the rising commonness of disease and other genetic irregularities.

The Rest of the World incorporates the Middle East, Africa, and Latin America. Middle East holds the significant market share in the Middle East and Africa region because of a few main considerations, for example, developing government support, rising public-private organizations, and expanded subsidizing are adding to the region's biotechnology industry's development.

Major Players

Key Companies in the Gene editing Market Include GE Healthcare (US), Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Lonza (Switzerland), GenScript (US), Horizon Discovery Ltd (UK), OriGene Technologies, Inc (US), Integrated DNA Technologies, Inc (US), New England Biolabs, Inc (US), and Sangamo Therapeutics (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING FUNDING FOR GENETIC RESEARCH
  • 4.2.2 RISING INCIDENCE OF GENETIC DISORDERS
  • 4.2.3 GROWING NUMBER OF STRATEGIC INITIATIVES
• 4.3 RESTRAINTS
  • 4.3.1 OFF-TARGET EFFECTS OF CRISPR TECHNOLOGY
  • 4.3.2 HIGH COST OF EQUIPMENT
• 4.4 OPPORTUNITIES
  • 4.4.1 INCREASING APPLICATION AREAS OF GENE EDITING

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL GENE EDITING MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON REGIONS
  • 5.3.3 IMPACT ON SUPPLY GAP ANALYSIS
  • 5.3.4 IMPACT ON PRICING

6 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY

• 6.1 OVERVIEW
• 6.2 CRISPR
• 6.3 TALEN
• 6.4 ZFN
• 6.5 ANTISENSE
• 6.6 OTHERS

7 GLOBAL GENE EDITING MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 GENETIC ENGINEERING
• 7.3 GENE THERAPY
• 7.4 CELL LINE ENGINEERING
• 7.5 OTHERS

8 GLOBAL GENE EDITING MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
• 8.3 CONTRACT RESEARCH ORGANIZATIONS
• 8.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

9 GLOBAL GENE EDITING MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 AFRICA
  • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL GENE EDITING MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL GENE EDITING MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT EXPANSION AND LAUNCH
  • 10.6.2 AGREEMENT/COLLABORATION
• 10.7 FINANCIAL MATRIX
  • 10.7.1 SALES (USD MILLION), 2021
  • 10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

• 11.1 BIO-RAD LABORATORIES, INC
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 GE HEALTHCARE
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 GENSCRIPT
  • 11.3.1 COMPANY OVERVIEWS
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 INTEGRATED DNA TECHNOLOGIES, INC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 NEW ENGLAND BIOLABS
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 SANGAMO THERAPEUTICS
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 THERMO FISHER SCIENTIFIC, INC
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 LONZA
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 HORIZON DISCOVERY LTD
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 ORIGENE TECHNOLOGIES, INC
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS